CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: December 22, 2003
Result type: Reports
Project Number: SR0003-000
Product Line: Reimbursement Review

Generic Name: Gefitinib

Brand Name: Iressa

Manufacturer: AstraZeneca

Therapeutic Area: Cancer, Lung , non-small cell

Indications: Cancer, Lung , non-small cell

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: June 23, 2004

Recommendation Type: Do not list